BioAtla (BCAB) Accumulated Depreciation (2020 - 2026)
BioAtla (BCAB) posted quarterly Accumulated Depreciation of $5.4 million for Q1 2026, down 24.46% year-over-year from $7.2 million in Q1 2025, and up 2.26% quarter-over-quarter from $5.3 million in Q4 2025.
BioAtla (BCAB) Accumulated Depreciation (2020 - 2026) Analysis & Trends
BioAtla's Accumulated Depreciation history runs 7 years deep, the most recent figure standing at $5.4 million for Q1 2026.
- In Q1 2026, Accumulated Depreciation fell 24.46% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $5.4 million (down 24.46% YoY), while the FY2025 annual figure was $5.3 million, down 24.2% from the prior year.
- Accumulated Depreciation for Q1 2026 stood at $5.4 million, up from $5.3 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $7.4 million in Q3 2025, with the low at $4.6 million in Q1 2022.
- The 5-year median for Accumulated Depreciation is $6.1 million (2023), against an average of $6.1 million.
- The sharpest annual moves came in 2022 and 2026: Accumulated Depreciation soared 34.98% in 2022, then decreased 24.46% in 2026.
- BioAtla's Accumulated Depreciation stood at $5.4 million in 2022, then climbed by 13.31% to $6.1 million in 2023, then rose by 15.22% to $7.0 million in 2024, then fell by 24.2% to $5.3 million in 2025, then grew by 2.26% to $5.4 million in 2026.
- Business Quant data shows BCAB's Accumulated Depreciation at $5.4 million in Q1 2026, $5.3 million in Q4 2025, and $7.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BioAtla | 5.41 Mn | 5.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.43 Mn |
| Mar 31, 2026 | 5.43 Mn |
| Dec 31, 2025 | 5.31 Mn |
| Sep 30, 2025 | 7.36 Mn |
| Jun 30, 2025 | 7.30 Mn |
| Mar 31, 2025 | 7.19 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 6.78 Mn |
| Jun 30, 2024 | 6.55 Mn |
| Mar 31, 2024 | 6.32 Mn |
| Dec 31, 2023 | 6.08 Mn |
| Sep 30, 2023 | 6.22 Mn |
| Jun 30, 2023 | 5.95 Mn |
| Mar 31, 2023 | 5.66 Mn |
| Dec 31, 2022 | 5.36 Mn |
| Sep 30, 2022 | 5.14 Mn |
| Jun 30, 2022 | 4.85 Mn |
| Mar 31, 2022 | 4.56 Mn |
| Dec 31, 2021 | 4.26 Mn |
| Sep 30, 2021 | 3.94 Mn |